Madison, WI, United States of America

Cellectar Biosciences, Inc.


USPTO Granted Patents = 8



Forward Citations = 20

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Jamey Paul Weichert (8 out of 44 patents)

silverMedal Anatoly Pinchuk (8 out of 29 patents)

bronzeMedal Marc Longino (8 out of 20 patents)

4 Chorom Pak (5 out of 7 patents)

5 Kevin Kozak (5 out of 5 patents)

6 Joseph J Grudzinski (4 out of 6 patents)

7 Benjamin Titz (4 out of 5 patents)

8 Nathan Stehle (4 out of 4 patents)

9 Irawati Kandela (1 out of 5 patents)

10 William R Clarke (1 out of 7 patents)

11 Jarrod Longcor (0 patent)


8 patents:

Cellectar Biosciences is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for cancer treatment. Their lead product candidate, CLR 131, is currently being evaluated in several clinical trials for a variety of cancers. The company's proprietary phospholipid drug conjugate platform enables the selective delivery of diverse oncologic payloads to cancer cells, offering a potentially more effective and less toxic treatment option for patients.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
8 Patents

#78 in Madison, WI

#776 in Wisconsin

#34,852 in US

...
Madison, WI, United States of America
Forward Citations = 20

12 inventors:

Please report any incorrect information to support@idiyas.com
Loading…